The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: sandostatin lar     Quarter: 2016Q3

Total Records: 1,320     Number of Pages: 66

DRUGNAME PT EventCount
SANDOSTATIN LAR DEPOT Sciatic nerve injury 12
SANDOSTATIN LAR DEPOT Therapy non-responder 12
SANDOSTATIN LAR DEPOT Anger 11
SANDOSTATIN LAR DEPOT Application site bruise 11
SANDOSTATIN LAR DEPOT Blood count abnormal 11
SANDOSTATIN LAR DEPOT Blood glucose abnormal 11
SANDOSTATIN LAR DEPOT Bone decalcification 11
SANDOSTATIN LAR DEPOT Carcinoid crisis 11
SANDOSTATIN LAR DEPOT Cardiac failure 11
SANDOSTATIN LAR DEPOT Chromosome analysis abnormal 11
SANDOSTATIN LAR DEPOT Clavicle fracture 11
SANDOSTATIN LAR DEPOT Eye swelling 11
SANDOSTATIN LAR DEPOT Furuncle 11
SANDOSTATIN LAR DEPOT Hallucination 11
SANDOSTATIN LAR DEPOT Head injury 11
SANDOSTATIN LAR DEPOT Incision site pain 11
SANDOSTATIN LAR DEPOT Joint stiffness 11
SANDOSTATIN LAR DEPOT Laceration 11
SANDOSTATIN LAR DEPOT Metastases to abdominal cavity 11
SANDOSTATIN LAR DEPOT Metastases to pancreas 11

Total Records: 1,320     Number of Pages: 66